Sexual Medicine Society of North America, Inc.

Scientific Program

Session type:
Person:
Clear filters

Morning

09:00 a.m. - 12:00 p.m.
APN-PA Symposium
Location: Grand Ballroom D
Moderator: Kenneth Mitchell, MPAS, PA-C

09:00 a.m. - 09:30 a.m.
Impact on Mental and Sexual Health Post Deployment
Penny K. Jensen, DNP, FNP, FAANP & Kenneth Mitchell, MPAS, PA-C

09:30 a.m. - 10:00 a.m.
Non-FDA Approved ED Management: The New Business of ED Therapy
John P. Mulhall, MD

10:00 a.m. - 10:30 a.m.
Communication with Patients
Bruce R. Kava, MD

10:30 a.m. - 11:00 a.m.
Evaluation and Management of Sexual Health Issues in the LGBTQ Community or Sex Therapy Basics for APP's?
Melissa A. Farmer, PhD

11:00 a.m. - 11:30 a.m.
The Role of a NP/PA in a Sexual and Reproductive Medicine Program
Lawrence C. Jenkins, MD, MBA

11:30 a.m. - 12:00 p.m.
Female Sexual Dysfunction
Irwin Goldstein, MD


Afternoon

12:00 p.m. - 01:30 p.m.
Industry Sponsored Lunch Symposium
Location: Grand Ballroom ABC

show program

01:30 p.m. - 02:30 p.m.
ESSM Symposium: Worst Cases
Location: Grand Ballroom D
Moderator: Francois Giuliano, MD, PhD

01:30 p.m. - 01:50 p.m.
Sexual Consequences of Post-SSRI Syndrome
Yacov Reisman, MD, PhD, FECSM

01:50 p.m. - 02:10 p.m.
Worst Cases of Penile Surgery
Carlo Bettocchi, MD

02:10 p.m. - 02:30 p.m.
Anteportal Ejaculation in Neurologic Patients
Francois Giuliano, MD, PhD


01:30 p.m. - 03:30 p.m.
Practice, Education and Sexual Pain
Location: Grand Ballroom EF
Moderators: Christian Nelson, PhD & Michael A. Perelman, PhD

01:30 p.m. - 01:45 p.m.
Point Counterpoint "Sex Therapy for PE is Necessary/Worthless" - Worthless
John P. Mulhall, MD

01:45 p.m. - 02:00 p.m.
Point Counterpoint "Sex Therapy for PE is Necessary/Worthless" - Necessary
Stanley Althof, PhD

02:00 p.m. - 02:15 p.m.
Treatment and Evaluation of Anorgasmia
Stacy L. Elliott, MD

02:15 p.m. - 02:30 p.m.
Climacturia
Brian S. Christine, MD

02:30 p.m. - 02:40 p.m.
Podium #001: Successful Integration of an Advanced Practice Practitioner (APP) into a Sexual and Reproductive Medicine Practice
Lawrence C. Jenkins, MD, MBA

02:40 p.m. - 02:45 p.m.
Poster #101: Emerging Data Regarding Trends in Surgical Education and Research Financial Relationships Between Device Manufacturers and Prosthetic Urologists
Martin Gross, MD

show poster

02:45 p.m. - 02:50 p.m.
Poster #102: Preparing Medical Students to Discuss Sexual Health with Adolescent Patients Through a Community Integrated Teaching Experience
C. Gutierrez

02:50 p.m. - 02:55 p.m.
Poster #103: Difficult Communication Skills Assessment Using Human Avatars: Piloting A Virtual World Objective Structured Clinical Examination (OSCE)
Bruce R. Kava, MD

show poster

02:55 p.m. - 03:00 p.m.
Poster #104: Protocol-Based Collaboration with Reconstructive Spine Surgery, Neurophysiology and Sexual Medicine for Diagnosis and Treatment of Neurogenic Sexual Dysfunctions
R.S. Rubin

show poster

03:00 p.m. - 03:05 p.m.
Poster #105: Factors Associated With Testicular Prostheses Availability and Implantation
J. Loh-Doyle

show poster

03:05 p.m. - 03:10 p.m.
Poster #106: Use of Zolpidem, a Non-Benzodiazepine Indirect GABA A Receptor Agonist, for Treatment of Persistent Genital Arousal Disorder (PGAD): Mechanism of Action and Preliminary Clinical Experience
A.G. Winter

show poster

03:10 p.m. - 03:15 p.m.
Poster #107: Influence of Reflux Flow Volume on Pain Resolution
H.S. Shin

show poster

03:15 p.m. - 03:20 p.m.
Poster #108: Microdenervation of the Spermatic Cord for Post Vasectomy Pain Syndrome- A Single Surgeon’s Experience
P.N. Tsambarlis

show poster

03:20 p.m. - 03:25 p.m.
Poster #109: Scrotal Pain After Microsurgical Denervation of the Spermatic: Patient Reported Quality of Life Outcomes
J. Basilius

show poster

03:25 p.m. - 03:30 p.m.
Q&A


01:30 p.m. - 03:30 p.m.
Peyronie’s Disease Medical
Location: Estrella Ballroom
Moderators: Lawrence S. Hakim, MD, FACS & Jesse N. Mills, MD

01:30 p.m. - 01:45 p.m.
Genetics of Peyronie’s Disease
Alexander W. Pastuszak, MD, PhD

01:45 p.m. - 01:55 p.m.
Podium #002: Penile Traction Does Not Improve Outcomes with Collagenase Clostridium Histolyticum for the Treatment of Peyronie’s Disease
M. Ziegelmann

01:55 p.m. - 02:05 p.m.
Podium #003: The Safety and Efficacy of Collagenase Clostridium Histolyticum (CCH) in Combination With Vacuum Therapy for the Treatment of Peyronie’s Disease
D. Ralph

02:05 p.m. - 02:15 p.m.
Podium #004: Safety and Effectiveness of Collagenase Clostridium Histolyticum (CCH- Xiapex®) in the Treatment of Peyronie's Disease Using a New Modified Protocol
A. Abdel Raheem

02:15 p.m. - 02:25 p.m.
Podium #005: Three Dimensional Photography for Qualitative and Quantitative Assessment of Penile Deformity
P.J. Stahl

02:25 p.m. - 02:35 p.m.
Podium #006: Safety and Efficacy of Collagenase Clostridium Histolyticum in the Treatment of Active Phase Peyronie's Disease
J. Anaissie

02:35 p.m. - 02:40 p.m.
Poster #110: Correlation of Clinical Meaningfulness and Curvature Improvement in Men Undergoing Collagenase Clostridium Histolyticum Injections for Peyronie’s Disease
M. Ziegelmann

show poster

02:40 p.m. - 02:45 p.m.
Poster #111: Ultrasound Measurement of Penile Plaque Size and Angle of Deformity following Intra-lesional Collagenase
M.S. Hockenberry

show poster

02:45 p.m. - 02:50 p.m.
Poster #112: Clinical Factors Negatively Impacting Sexual Relationships in Men with Peyronie’s Disease
M. Ziegelmann

show poster

02:50 p.m. - 02:55 p.m.
Poster #113: Intralesional Collagenase Clostridium Histolyticum Does Not Change Penile Vascular Parameters In Men With Peyronie's Disease
J. Anaissie

02:55 p.m. - 03:00 p.m.
Poster #114: Analysis of the Psychosocial Impact of Peyronie’s Disease
John P. Mulhall, MD

03:00 p.m. - 03:05 p.m.
Poster #115: Collagenase Clostridium Histolyticum: Do Intra-Lesional Injections Increase the Risk of Late-Onset Penile Fracture?
J.J. Wallen

show poster

03:05 p.m. - 03:10 p.m.
Poster #116: A Retrospective Review of Protocol-Based Intralesional Injection Therapy Management of Peyronie’s Disease at the La Jolla Veteran’s Administration Medical Center (VAMC)
S.A. King

03:10 p.m. - 03:15 p.m.
Poster #117: The Use of Collagenase Clostridium Histolyticum in the Management of Peyronie’s Disease: A Single Center Experience
P.N. Tsambarlis

show poster

03:15 p.m. - 03:20 p.m.
Poster #118: Initial Degree of Penile Curvature Predicts Absolute but Not Relative Curvature Improvement with Collagenase Clostridium Histolyticum for Peyronie’s Disease
M. Ziegelmann

show poster

03:20 p.m. - 03:25 p.m.
Poster #119: Outcomes of Tunica Albuginea Plication for Peyronie’s Disease with Limited Use of Permanent Suture
D. Papagiannopoulos

show poster

03:25 p.m. - 03:30 p.m.
Poster #120: A Multi-Institutional Retrospective Study on Safety, Usage, and Quantity of ProFlo, an Amniotic Fluid Injectable, used in the treatment of Erectile Dysfunction and Peyronie’s Disease
Michael P. Zahalsky, MD

show poster


02:30 p.m. - 03:30 p.m.
ISSM Symposium
Location: Grand Ballroom D
Moderators: Gerald B. Brock, MD & Luca Incrocci, MD, PhD

02:30 p.m. - 02:45 p.m.
Update from the ISSM WMSM in Beijing, China
Wayne J.G. Hellstrom, MD

02:45 p.m. - 03:00 p.m.
Medication for Female Sexual Dysfunctions – Where are we?
Annamaria Giraldi, MD, PhD

03:00 p.m. - 03:15 p.m.
Do Modern Techniques for Radiotherapy of Prostate Cancer Really Matter in Decreasing Erectile Dysfunction?
Luca Incrocci, MD, PhD

03:15 p.m. - 03:30 p.m.
The Role of Testosterone in the Sexual Function
Luiz Otavio Torres, MD


03:30 p.m. - 04:00 p.m.
Coffee Break
Location: Foyer


04:00 p.m. - 06:00 p.m.
Hormones
Location: Grand Ballroom D
Moderators: Mohit Khera, MD & Brian Steixner, MD

04:00 p.m. - 04:15 p.m.
The History of Testosterone Therapy
Abraham Morgentaler, MD

04:15 p.m. - 04:30 p.m.
Actual Candidates for Low Testosterone Therapy
William P. Conners, MD

04:30 p.m. - 04:40 p.m.
Podium #014: Saferty and Efficacy Results from the Phase-3, Double-blind, Multicenter Steady Trial of a Novel, Pre-filled, Subcateneous (SC) Auto-injector for Testosterone (T) Replacement Therapy
R. Swerdloff

04:40 p.m. - 04:50 p.m.
Podium #015: Male Non-Standard Shift Workers Are Predisposed to Depression and Hypogonadal Symptoms
Alexander W. Pastuszak, MD, PhD

04:50 p.m. - 05:00 p.m.
Podium #016: Long-term Testosterone Treatment Improves Urinary and Sexual Function in Hypogonadal Men - Results from a Propensity-matched Subgroup of a Controlled Registry Study
F. Saad

05:00 p.m. - 05:10 p.m.
Podium #017: Safety of Testosterone Therapy in Patients on Active Surveillance for Prostate Cancer
Lawrence C. Jenkins, MD, MBA

05:10 p.m. - 05:15 p.m.
Poster #130: Long-term Testosterone Treatment Improves Glycemic Control in Hypogonadal Men - Results from a Propensity-matched Subgroup of a Controlled Registry Study
F. Saad

show poster

05:15 p.m. - 05:20 p.m.
Poster #131: Correlation between androgen receptor CAG repeat length polymorphism and metabolic syndrome, late onset hypogonadism in Korean male
D.G. Moon

05:20 p.m. - 05:25 p.m.
Poster #132: Long-Term Testosterone Treatment Leads to Sustained Weight Loss in Hypogonadal Men - Results from a Propensity-matched Subgroup of a Controlled Registry Study
F. Saad

show poster

05:25 p.m. - 05:30 p.m.
Poster #133: Grey-Scale Penile Ultrasound Findings in Young Men with Erectile Dysfunction (ED) Who Used Finasteride for Androgenic Alopecia: A Retrospective Review
Irwin Goldstein, MD

show poster

05:30 p.m. - 05:35 p.m.
Poster #134: Improvements in Psychosexual Function among Hypogonadal Men Enrolled in the Steady Trial of a Novel, Subcutaneous Auto-injector for Testosterone Replacement
C. Wang

show poster

05:35 p.m. - 05:40 p.m.
Poster #135: Testosterone for Sale: An Unsafe Internet Alternative
A. Herati

05:40 p.m. - 05:45 p.m.
Poster #136: Calculated Free T and T:E Ratio but not Total Testosterone and Estradiol Predict Low Libido
N. Gupta

show poster

05:45 p.m. - 05:50 p.m.
Poster #137: Impact of Testosterone Replacement Therapy in Men with Adult Onset Hypogonadism after Issuance of 2014 Food and Drug Administration Safety Communication
D. Shin

show poster

05:50 p.m. - 05:55 p.m.
Poster #138: Comparison of RIA and LCMS in the Measurement of Baseline T and Response to Enclomiphene
Andrew R. McCullough, MD

show poster

05:55 p.m. - 06:00 p.m.
Poster #139: Gaps in Patient Knowledge about the Risks and Benefits Associated with Testosterone Replacement Therapy
K. Gilbert

show poster


04:00 p.m. - 06:00 p.m.
Incontinence and Reconstruction
Location: Grand Ballroom EF
Moderators: Ryan Terlecki, MD & Lee Zhao, MD

04:00 p.m. - 04:10 p.m.
Podium #007: Device Survival Following Primary Implantation of the AMS 800 Artificial Urinary Sphincter for Male Stress Urinary Incontinence
Faysal A. Yafi, MD, FRCSC

04:10 p.m. - 04:20 p.m.
Podium #008: Transcorporal Artificial Urinary Sphincter Placement in Patients with Prior Inflatable Penile Prosthesis Utilizing 6-ply Acellular Graft: A Novel Technique with Resolution of Climacturia
M. Mendez

04:20 p.m. - 04:30 p.m.
Podium #009: The Utilization of a Dedicated Sexual Health and Pelvic Floor Physiotherapy Service for Urinary Incontinence and Erectile Dysfunction after Prostate Cancer Diagnosis
Stacy L. Elliott, MD

04:30 p.m. - 04:40 p.m.
Podium #010: Urethral Stricture Outcomes after AUS Cuff Erosion: Results From a Multicenter Retrospective Analysis
Martin Gross, MD

04:40 p.m. - 04:50 p.m.
Podium #011: Outcomes after AUS Replacement due to Cuff Erosion: Results from a Multicenter Retrospective Analysis
James R. Craig Jr., MD

04:50 p.m. - 05:00 p.m.
Podium #012: Modified Fasciocutaneous Ventral Transverse Island Flap for Treatment of Fossa Navicularis Strictures
N.V. Johnsen

05:00 p.m. - 05:10 p.m.
Podium #013: Molded Collagen Scaffolds as an Engineered Replacement for Biological-sourced Materials in Reconstructive Urological Applications
N. Sopko

05:10 p.m. - 05:15 p.m.
Poster #121: Climacturia Following Radical Prostatectomy: The Time is Now to Query and Treat
Brian S. Christine, MD

05:15 p.m. - 05:20 p.m.
Poster #122: Salvage of Climacturia Non-surgical Treatment Failures using a Patient and Partner-friendly Novel Soft Silicone Occlusion Loop during Sexual Activity
A.J. Bella

05:20 p.m. - 05:25 p.m.
Poster #123: Bladder Training can be Helpful for Continence Recovery in Early Postprostatectomy Phase
D.S. Park

show poster

05:25 p.m. - 05:30 p.m.
Poster #124: Clinical Effectiveness of Xhold® for Male Urinary Incontinence
N.C. Park

05:30 p.m. - 05:35 p.m.
Poster #125: Case Report: Worsening Male Stress Urinary Incontinence and Delayed Urethral Erosion of the Bulking Agent after Intraurethral Injection of Macroplastique
D.G. Song

show poster

05:35 p.m. - 05:40 p.m.
Poster #126: Natural History and Predictors of Erectile Function Following Pelvic Fracture Urethral Injury
N.V. Johnsen

show poster

05:40 p.m. - 05:45 p.m.
Poster #127: Comparative Efficacy of Z-Plasty for Patients with Adult Buried Penis
N.V. Johnsen

show poster

05:45 p.m. - 05:50 p.m.
Poster #128: Surgical Excision for Management of Genital Giant Condyloma Acuminata
A. Radtke

05:50 p.m. - 05:55 p.m.
Poster #129: Single Incision Vasectomy Reversal (SIVR) – Less Pain Without Compromising Surgical Outcomes
E. Grober

show poster

05:55 p.m. - 06:00 p.m.
Q&A


04:00 p.m. - 06:00 p.m.
Erectile Dysfunction Epidemiology and Medical
Location: Estrella Ballroom
Moderators: James M. Hotaling, MD, MS, FECSM & Faysal A. Yafi, MD, FRCSC

04:00 p.m. - 04:10 p.m.
Podium #018: A Prospective Examination of Erectile Function Preservation After Radiation Therapy
Lawrence C. Jenkins, MD, MBA

04:10 p.m. - 04:20 p.m.
Podium #019: Assessing the Variability in Insurance Coverage Transparency for Male Sexual Health Conditions in the United States
B. Le

04:20 p.m. - 04:30 p.m.
Podium #020: Increased Nocturnal Penile Tumescence in the Acute Phase after Nerve-sparing Radical Prostatectomy with “Early” Administration of Low-dose Tadalafil is Correlated with further Erectile Function Rehabilitation
A. Bannowsky

04:30 p.m. - 04:40 p.m.
Podium #021: Cessation of Phosphodiesterase 5 Inhibitor Use in Men with Erectile Dysfunction Following Testosterone Therapy
Alexander W. Pastuszak, MD, PhD

04:40 p.m. - 04:50 p.m.
Podium #022: Cardiology Referrals, Cardiac Risk Stratification and Cardiac Catheterizations Procedures Generated From A High Volume Erectile Dysfunction Practice
Brian Steixner, MD

04:50 p.m. - 04:55 p.m.
Poster #140: Does Neoadjuvant Androgen Deprivation Therapy Impact Erectile Function Recovery Post-Radical Prostatectomy?
Lawrence C. Jenkins, MD, MBA

show poster

04:55 p.m. - 05:00 p.m.
Poster #141: Reproductive Knowledge And Attitudes Of Patients Undergoing Radical Prostatectomy
Nelson Bennett Jr., MD

05:00 p.m. - 05:05 p.m.
Poster #142: The Approved Harmonized Version of the International Index of Erectile Function into Kinyarwanda, the native language of Rwanda
R. Grunert

show poster

05:05 p.m. - 05:10 p.m.
Poster #143: What Patients and Partners Want in Interventions That Support Sexual Recovery After Prostate Cancer Treatment
A. Mehta

show poster

05:10 p.m. - 05:15 p.m.
Poster #144: Abnormal Penile Duplex Ultrasound Findings Are Associated with Elevated Serum Biomarkers of Vascular Inflammation
S.J. Ohlander

05:15 p.m. - 05:20 p.m.
Poster #145: Is there a Relationship between Phosphodiesterase Type 5 Inhibitors (PDE5i) and Prostate Cancer Biochemical Recurrence?
Lawrence C. Jenkins, MD, MBA

show poster

05:20 p.m. - 05:25 p.m.
Poster #146: The Efficacy of Platelet-Rich Plasma (PRP) as a Supplemental Therapy for the Treatment of Erectile Dysfunction (ED): Initial Outcomes
J.J. Banno

show poster

05:25 p.m. - 05:30 p.m.
Poster #147: Clinical Characteristics of Young Men with Erectile Dysfunction
R. Avant

05:30 p.m. - 05:35 p.m.
Poster #148: Sacubitril/Valsartan (ENTRESTO®) and Valsartran/Sildenafil Combination Improves Functional Responses on Isolated Rat Corpus Cavernosum from Nerve-Crush Injury Model
K.J. DeLay

show poster

05:35 p.m. - 05:40 p.m.
Poster #149: Ethnicity and Age as Factors in Sildenafil Treatment of Erectile Dysfunction
D.A. Ohl

show poster

05:40 p.m. - 05:45 p.m.
Poster #150: Predictors of Increased Intracavernosal Injection Requirements at Penile Ultrasound
R. Avant

show poster

05:45 p.m. - 05:50 p.m.
Poster #151: Sexual Frequency in a Cardiovascular Clinic Population
W. Baas

show poster

05:50 p.m. - 06:00 p.m.
Q&A


Evening

06:00 p.m. - 07:30 p.m.
Welcome Reception
Location: Foyer


Our Services

About SMSNA

Established in 1994, our objective has been to promote, encourage, and support the highest standards of practice, research, education, and ethics in the study of the anatomy, physiology, pathophysiology, diagnosis, and treatment...

~ Read More

Contact Us

SMSNA Executive Office
c/o Status Plus
+1 (952) 683 1917
+1 (612) 808 0491
info@smsna.org

Address
14305 Southcross Dr
Suite 100
Burnsville MN, 55306